Inventor · Belmont, MA, US

Tesfaye Biftu

84Patents
13h-index
167Co-inventors
87Inventor score

Filing activity: Oct 8, 1982 → Aug 12, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US5780503A Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders Chemistry; Metallurgy 68 Expired
US5463083A Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders Chemistry; Metallurgy 58 Expired
US5792776A Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders Chemistry; Metallurgy 47 Expired
US5741809A Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders Chemistry; Metallurgy 46 Expired
US4539332A 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists Chemistry; Metallurgy 35 Expired
US4757084A 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists Chemistry; Metallurgy 27 Expired
US4595693A Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists Chemistry; Metallurgy 27 Expired
US6034106A Oxadiazole benzenesulfonamides as selective .beta..sub.3 Agonist for the treatment of Diabetes and Obesity Chemistry; Metallurgy 24 Expired
US5001123A 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists Chemistry; Metallurgy 18 Expired
US4996203A 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists Chemistry; Metallurgy 18 Expired
US5369125A Cholesterol-lowering agents Chemistry; Metallurgy 18 Expired
US5047420A 1,3-diaryl cyclopentanes and derivatives thereof as PAF antagonists Chemistry; Metallurgy 14 Expired
US4977146A 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists Human Necessities 13 Expired
US9227972B2 Aliphatic spirolactam CGRP receptor antagonists Human Necessities 13 Active
US9296750B2 Spirolactam CGRP receptor antagonists Chemistry; Metallurgy 12 Active
US9227973B2 Pyridine CGRP receptor antagonists Chemistry; Metallurgy 12 Active
US7678905B2 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Chemistry; Metallurgy 10 Active
US8980929B2 Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes Chemistry; Metallurgy 10 Active
US4536512A 5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2,3-dihyd ro-1H-pyrrolizine-1-alkanoic or carboxylic acids and use thereof as anti-inflammatory and analgesic agents Chemistry; Metallurgy 10 Expired
US6201016A Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders Chemistry; Metallurgy 9 Expired
US8143289B2 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Chemistry; Metallurgy 9 Active
US5010100A Certain 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists Chemistry; Metallurgy 8 Expired
US6077846A Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists Human Necessities 8 Expired
US7196095B2 (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds Chemistry; Metallurgy 7 Expired
US4511724A 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents Chemistry; Metallurgy 7 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.